Skip to Content
A home for paediatricians. A voice for children and youth.

Advocacy










Pharmacare in Canada: The Paediatric Perspective

Posted: Sep 26, 2019 | Reaffirmed: Jan 12, 2026

Committee(s): Paediatric Drugs and Therapeutics Task Force

Topic(s): advocacy, drug therapy

Disclaimer: The recommendations in this position statement do not indicate an exclusive course of treatment or procedure to be followed. Variations, taking into account individual circumstances, may be appropriate. Internet addresses are current at time of publication.